NCT00439179View on ClinicalTrials.gov

A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Metastatic Pancreatic Cancer
Interventions
DRUG

cohort 1

Weekly gem + GW572016, 1000mg/day (combination)

DRUG

cohort 2

Weekly gem + GW572016, 1500 mg/day (combination)

DRUG

cohort 3

GEMOX + GW572016 1000 mg/day (combination)

DRUG

cohort 4

GEMOX + GW572016 1500 mg/day (combination)

Trial Locations (1)

02903

Brown University Oncology Research Group, Providence

Sponsors

Lead Sponsor

Brown University

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Brown University

OTHER

NCT00439179 - A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema | Biotech Hunter | Biotech Hunter